← Back to headlines
Merck's TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints
Merck announced that its Phase 3 TroFuse-005 trial, investigating a treatment for endometrial cancer, successfully met its primary endpoints, marking a significant development in oncology.
23 May, 12:01 — 23 May, 12:01
Sources
Showing 1 of 1 sources
Related Stories
Mother and Daughter Die After Rain-Triggered Wall Collapse in Spain
49m ago
Motorcyclist Dies in Crash on Athens-Lamia Highway Near Metamorfosi
54m ago
Study Finds Nicotine Vapes Most Effective Tool for Smoking Cessation
1h ago
Chinese Teenagers Increasingly Turn to Prescription Drugs to Cope with Stress
1h ago